Relapsing-remitting multiple sclerosis is a type of multiple sclerosis ... MS is a chronic, progressive condition of the central nervous system (CNS) in which your immune system attacks myelin ...

Up to 85% of the people who receive a diagnosis of the neurodegenerative disorder multiple sclerosis ... that primary ...

Patients with multiple sclerosis (MS) most commonly have a relapsing-remitting course followed eventually by a secondary progressive phase. During this latter period, disability relentlessly ...

So we'll go online, and I'll see this relapsing, remitting, and primary progressive and secondary progression. All of those names were derived when we didn't really understand the disease as much ...

Let's talk about how multiple sclerosis impacts cognitive function ... which occurs in both relapsing MS and in the progressive forms of MS can perpetuate depression, and that brain fog, slowing ...

Multiple sclerosis (MS ... and about 2.9 million people worldwide. There are relapsing-remitting and progressive types of MS, but the course is rarely predictable. Researchers still don’t ...

A biological, mechanism-based framework to reclassify multiple sclerosis (MS ... non-overlapping categories -- i.e., ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

Multiple Sclerosis (MS) is an autoimmune ... Progressive MS: Previously, progressive forms of MS were divided into Secondary Progressive – arising from prior Relapsing MS – and Primary Progressive – ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

The following is a summary of “Cost–consequence analysis of early vs. delayed natalizumab use in highly active ...

RRMS is the most common type of multiple sclerosis ... including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.